{
    "title": "FDA panel backs Amgen cholesterol drug for some patients",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3118995/FDA-panel-backs-Amgen-cholesterol-drug-patients.html",
    "date": "2015-06-10",
    "keywords": [
        "cholesterol",
        "drug",
        "percent",
        "panel",
        "amgen",
        "fda",
        "class",
        "sanofi",
        "pcsk9",
        "trading",
        "gmt",
        "june",
        "health",
        "repatha",
        "study",
        "heart",
        "death",
        "statin",
        "treatment",
        "regeneron",
        "substance",
        "ldl",
        "year",
        "disease",
        "press",
        "email",
        "washington",
        "wednesday",
        "inc",
        "substancebut",
        "review",
        "day",
        "food",
        "administration",
        "benefitthe",
        "highrisk",
        "advice",
        "endorsement",
        "attack",
        "question",
        "arent",
        "part",
        "biotech",
        "yearsamgen",
        "vote",
        "tuesday",
        "praluentan",
        "approval",
        "decision",
        "month",
        "target",
        "dateboth",
        "lowdensity",
        "lipoprotein",
        "way",
        "ability",
        "blood",
        "waxlike",
        "company",
        "group",
        "marketsbut",
        "prospect",
        "america",
        "none",
        "pricing",
        "industry",
        "drugsmore",
        "control",
        "prevention",
        "risk",
        "cause",
        "week",
        "condition",
        "statinshow",
        "label",
        "agency",
        "languageamgen",
        "statement",
        "need",
        "patient",
        "thousand",
        "afterhours",
        "york"
    ],
    "category": [
        "wires",
        "ap"
    ]
}